Your browser doesn't support javascript.
loading
Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a single integrated health network.
Wiederkehr, Daniel; Berenson, Karina; Casciano, Roman; Stern, Lee; Makenbaeva, Dinara; Mozaffari, Essy; Lamerato, Lois; Corbelli, John.
Afiliação
  • Wiederkehr D; Analytica International, New York, NY, USA.
Curr Med Res Opin ; 25(9): 2317-25, 2009 Sep.
Article em En | MEDLINE | ID: mdl-19635042
OBJECTIVE: To determine the association between the discontinuation of clopidogrel therapy prior to 1 year and the risk of acute myocardial infarction (AMI) hospitalization, coronary intervention or all-cause mortality in a cohort of managed-care patients following AMI hospitalization or stent insertion. RESEARCH DESIGN AND METHODS: This observational cohort study included 1152 patients enrolled in the Health Alliance Plan who were hospitalized for AMI, or who underwent coronary stent placement. Clopidogrel use was assessed using pharmacy claims data. The association between discontinuation of clopidogrel prior to 1 year following the initial ACS event and the primary outcome of AMI hospitalization/procedure was assessed using Cox proportional hazards models. Additionally, an analysis was conducted to determine the association of discontinuation prior to 1 year with a secondary composite outcome of AMI hospitalization/coronary stent procedure or all-cause mortality. MAIN OUTCOME MEASURES: The primary outcome was AMI hospitalization or procedure. The secondary outcome was a composite of AMI hospitalization/ procedure, or all-cause mortality. RESULTS: Discontinuation of clopidogrel in the total cohort of patients was associated with a significantly higher risk of the primary outcome of AMI hospitalization/ coronary intervention (HR 2.712, 95% CI 1.634-4.502). Consistent with this finding, discontinuation of clopidogrel was also associated with a significantly higher risk of the secondary composite endpoint (HR 1.844, 95% CI 1.281-2.653). CONCLUSIONS: In patients enrolled in an integrated health network, clopidogrel discontinuation prior to 1 year following AMI hospitalization or stent placement is associated with adverse outcomes including greater risk of death, AMI hospitalization or coronary intervention. These results should be interpreted within the context and limitations of observational research, which cannot attribute causality.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Procedimentos Cirúrgicos Cardiovasculares / Ticlopidina / Stents / Doença das Coronárias / Suspensão de Tratamento / Hospitalização / Infarto do Miocárdio Tipo de estudo: Etiology_studies / Evaluation_studies / Incidence_studies / Observational_studies / Prognostic_studies Idioma: En Revista: Curr Med Res Opin Ano de publicação: 2009 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Procedimentos Cirúrgicos Cardiovasculares / Ticlopidina / Stents / Doença das Coronárias / Suspensão de Tratamento / Hospitalização / Infarto do Miocárdio Tipo de estudo: Etiology_studies / Evaluation_studies / Incidence_studies / Observational_studies / Prognostic_studies Idioma: En Revista: Curr Med Res Opin Ano de publicação: 2009 Tipo de documento: Article País de afiliação: Estados Unidos